Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Progress and trends in complement therapeutics.

Ricklin D, Lambris JD.

Adv Exp Med Biol. 2013;735:1-22. Review.

PMID:
23402016
2.

Progress and Trends in Complement Therapeutics.

Ricklin D, Lambris JD.

Adv Exp Med Biol. 2013;735:1-22.

3.

Complement-targeted therapeutics.

Ricklin D, Lambris JD.

Nat Biotechnol. 2007 Nov;25(11):1265-75. Review.

4.

Complement in action: an analysis of patent trends from 1976 through 2011.

Yang K, DeAngelis RA, Reed JE, Ricklin D, Lambris JD.

Adv Exp Med Biol. 2013;735:301-13. Review.

PMID:
23402036
5.

Complement and membrane-bound complement regulatory proteins as biomarkers and therapeutic targets for autoimmune inflammatory disorders, RA and SLE.

Das N.

Indian J Exp Biol. 2015 Nov;53(11):701-13. Review. Erratum in: Indian J Exp Biol. 2016 Jan;54(1):76.

PMID:
26669012
6.
7.

The case for complement and inflammation in AMD: open questions.

Karagianni N, Adamis AP.

Adv Exp Med Biol. 2010;703:1-7. doi: 10.1007/978-1-4419-5635-4_1. Review.

PMID:
20711703
8.

[Artificial inhibition of the complement system].

Kozlov LV, Burdelev OO, Bureeva SV, Kaplun AP.

Bioorg Khim. 2007 Sep-Oct;33(5):485-510. Review. Russian.

PMID:
18050655
9.

Modulators of complement activation: a patent review (2008 - 2013).

Larghi EL, Kaufman TS.

Expert Opin Ther Pat. 2014 Jun;24(6):665-86. doi: 10.1517/13543776.2014.898063. Review.

PMID:
24640971
10.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
11.

Therapeutic complement inhibition – from experimental to clinical medicine.

Lappegård KT, Bjerre A, Tjønnfjord GE, Mollnes TE.

Tidsskr Nor Laegeforen. 2015 Oct 20;135(19):1745-9. doi: 10.4045/tidsskr.15.0049. Review. English, Norwegian.

12.

Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention.

Mastellos DC, Ricklin D, Hajishengallis E, Hajishengallis G, Lambris JD.

Mol Oral Microbiol. 2016 Feb;31(1):3-17. doi: 10.1111/omi.12129. Review.

13.

Novel roles of complement in renal diseases and their therapeutic consequences.

Wada T, Nangaku M.

Kidney Int. 2013 Sep;84(3):441-50. doi: 10.1038/ki.2013.134. Review.

PMID:
23615508
14.

Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention.

Mastellos DC, Yancopoulou D, Kokkinos P, Huber-Lang M, Hajishengallis G, Biglarnia AR, Lupu F, Nilsson B, Risitano AM, Ricklin D, Lambris JD.

Eur J Clin Invest. 2015 Apr;45(4):423-40. doi: 10.1111/eci.12419. Review.

15.

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria.

Rother RP, Rollins SA, Mojcik CF, Brodsky RA, Bell L.

Nat Biotechnol. 2007 Nov;25(11):1256-64. Erratum in: Nat Biotechnol. 2007 Dec;25(12):1488.

PMID:
17989688
16.

The role of the complement system in acute kidney injury.

McCullough JW, Renner B, Thurman JM.

Semin Nephrol. 2013 Nov;33(6):543-56. doi: 10.1016/j.semnephrol.2013.08.005. Review.

17.

Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics.

Mehan MR, Ostroff R, Wilcox SK, Steele F, Schneider D, Jarvis TC, Baird GS, Gold L, Janjic N.

Adv Exp Med Biol. 2013;735:283-300. Review.

PMID:
23402035
18.

Complement, a target for therapy in inflammatory and degenerative diseases.

Morgan BP, Harris CL.

Nat Rev Drug Discov. 2015 Dec;14(12):857-77. doi: 10.1038/nrd4657. Review.

PMID:
26493766
19.

Complement in therapy and disease: Regulating the complement system with antibody-based therapeutics.

Melis JP, Strumane K, Ruuls SR, Beurskens FJ, Schuurman J, Parren PW.

Mol Immunol. 2015 Oct;67(2 Pt A):117-30. doi: 10.1016/j.molimm.2015.01.028. Review.

20.

Therapeutic targeting of the complement system in age-related macular degeneration: a review.

Troutbeck R, Al-Qureshi S, Guymer RH.

Clin Exp Ophthalmol. 2012 Jan-Feb;40(1):18-26. doi: 10.1111/j.1442-9071.2011.02581.x. Review.

PMID:
22304025
Items per page

Supplemental Content

Support Center